Cargando…

SARS-CoV-2 seroprevalence, and IgG concentration and pseudovirus neutralising antibody titres after infection, compared by HIV status: a matched case-control observational study

BACKGROUND: Most cohorts show similar or lower COVID-19 incidence among people living with HIV compared with the general population. However, incidence might be affected by lower testing rates among vulnerable populations. We aimed to compare SARS-CoV-2 IgG seroprevalence, disease severity, and neut...

Descripción completa

Detalles Bibliográficos
Autores principales:	Spinelli, Matthew A, Lynch, Kara L, Yun, Cassandra, Glidden, David V, Peluso, Michael J, Henrich, Timothy J, Gandhi, Monica, Brown, Lillian B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084354/ https://www.ncbi.nlm.nih.gov/pubmed/33933189 http://dx.doi.org/10.1016/S2352-3018(21)00072-2

Ejemplares similares

LB8. Lower SARS-CoV-2 IgG and Pseudovirus Neutralization Titers Post-mRNA Vaccination among People Living with HIV
por: Spinelli, Matthew A, et al.
Publicado: (2021)

Differences in Post-mRNA Vaccination Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Immunoglobulin G (IgG) Concentrations and Surrogate Virus Neutralization Test Response by Human Immunodeficiency Virus (HIV) Status and Type of Vaccine: A Matched Case-Control Observational Study
por: Spinelli, Matthew A, et al.
Publicado: (2021)

Intracellular neutralisation of rotavirus by VP6-specific IgG
por: Caddy, Sarah L., et al.
Publicado: (2020)

High-throughput analysis of anti-poliovirus neutralization antibody titre in human serum by the pseudovirus neutralization test
por: Arita, Minetaro, et al.
Publicado: (2022)

Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants
por: Pallett, Scott J C, et al.
Publicado: (2022)

Stimulation of rotavirus IgA, IgG and neutralising antibodies in baboon milk by parenteral vaccination
por: Snodgrass, D.R., et al.
Publicado: (1995)

Chronological evolution of IgM, IgA, IgG and neutralisation antibodies after infection with SARS‐associated coronavirus
por: Hsueh, P.‐R., et al.
Publicado: (2004)

Estimation of anti-SARS-CoV-2 IgG titre among blood donors in Ranchi
por: Kumari, Sushma, et al.
Publicado: (2022)

Serum MOG IgG titres should be performed routinely in the diagnosis and follow-up of MOGAD: Yes
por: Reindl, Markus, et al.
Publicado: (2023)

SARS-CoV-2 neutralising antibody testing in Europe: towards harmonisation of neutralising antibody titres for better use of convalescent plasma and comparability of trial data
por: Nguyen, Dung, et al.
Publicado: (2021)

Effect of recurrent invasive pneumococcal disease on serum anti-pneumolysin IgG titres in HIV infected adults
por: Etuwewe, Onajite M., et al.
Publicado: (2009)

The seroprevalence and kinetics of IgM and IgG in the progression of COVID-19
por: Qin, Xuzhen, et al.
Publicado: (2021)

Ebola Virus IgG Seroprevalence in Southern Mali
por: Bane, Sidy, et al.
Publicado: (2021)

Trimer IgG and neutralising antibody response to COVID-19 mRNA vaccination in individuals with sarcoidosis
por: Vagts, Christen L., et al.
Publicado: (2023)

Neutralising activity and antibody titre in 10 patients with breakthrough infections of the SARS-CoV-2 Omicron variant in Japan
por: Okumura, Nobumasa, et al.
Publicado: (2022)

Seroprevalence of CMV IgG and IgM in Korean women of childbearing age
por: Choi, Rihwa, et al.
Publicado: (2021)

Seroprevalence of diphtheria toxoid IgG antibodies in the Malaysian population
por: Yusoff, Ahmad Faudzi, et al.
Publicado: (2021)

Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis
por: Cromer, Deborah, et al.
Publicado: (2022)

Sero-Monitoring of Horses Demonstrates the Equivac(®) HeV Hendra Virus Vaccine to Be Highly Effective in Inducing Neutralising Antibody Titres
por: Halpin, Kim, et al.
Publicado: (2021)

Kinetics of IgG antibody to cytomegalovirus (CMV) after birth and seroprevalence of anti-CMV IgG in Chinese children
por: Chen, Jie, et al.
Publicado: (2012)

Comparing the performance of dengue virus IgG and IgG-capture enzyme-linked immunosorbent assays in seroprevalence study
por: Tsai, Jih-Jin, et al.
Publicado: (2023)

The seroprevalence of Mycoplasma pneumoniae IgM and IgG antibodies in patients with ischemic stroke
por: Roham, Maryam, et al.
Publicado: (2016)

Seroprevalence of Rubella IgG Antibody in Pregnant Women in Osogbo, Nigeria
por: Kolawole, Olatunji Mathew, et al.
Publicado: (2014)

58: Seroprevalence of COVID-19 IgG in the cystic fibrosis population
por: Mahan, K., et al.
Publicado: (2021)

Correction to: Comparing the performance of dengue virus IgG and IgG-capture enzyme-linked immunosorbent assays in seroprevalence study
por: Tsai, Jih-Jin, et al.
Publicado: (2023)

Optimising the IgG‐degrading enzyme treatment regimen for enhanced adeno‐associated virus transduction in the presence of neutralising antibodies
por: Ros‐Gañán, Irene, et al.
Publicado: (2022)

Induction of high titred, non-neutralising antibodies by self-adjuvanting peptide epitopes derived from the respiratory syncytial virus fusion protein
por: Jaberolansar, Noushin, et al.
Publicado: (2017)

Neutralisation titres against SARS-CoV-2 are sustained 6 months after onset of symptoms in individuals with mild COVID-19
por: Underwood, Alexander P., et al.
Publicado: (2021)

Sociodemographic factors associated with IgG and IgM seroprevalence for human cytomegalovirus infection in adult populations of Pakistan: a seroprevalence survey
por: Ibrahim, Saira, et al.
Publicado: (2016)

SARS-CoV-2 antibody prevalence, titres and neutralising activity in an antenatal cohort, United Kingdom, 14 April to 15 June 2020
por: Lumley, Sheila F, et al.
Publicado: (2020)

A therapeutic Porphyromonas gingivalis gingipain vaccine induces neutralising IgG1 antibodies that protect against experimental periodontitis
por: O’Brien-Simpson, Neil M, et al.
Publicado: (2016)

Seroprevalence of diphtheria toxoid IgG antibodies in children, adolescents and adults in Poland
por: Zasada, Aleksandra A, et al.
Publicado: (2013)

Seroprevalences of Specific IgG Antibodies to Measles, Mumps, and Rubella in Korean Infants
por: Cho, Hye-Kyung, et al.
Publicado: (2016)

Determination of Seroprevalence of Borrelia burgdorferi IgG in Adult Population Living in Trabzon
por: Cora, Merve, et al.
Publicado: (2017)

Seroprevalence and clinical phenotype of MOG-IgG-associated disorders in Sri Lanka
por: Senanayake, Bimsara, et al.
Publicado: (2019)

Seroprevalence of Aspergillus-Specific IgG Antibody among Mozambican Tuberculosis Patients
por: Salzer, Helmut J. F., et al.
Publicado: (2021)

Temporally separated feline calicivirus isolates do not cluster phylogenetically and are similarly neutralised by high-titre vaccine strain FCV-F9 antisera in vitro
por: Smith, Shirley L, et al.
Publicado: (2019)

Correlating IgG Levels with Neutralising Antibody Levels to Indicate Clinical Protection in Healthcare Workers at Risk during a Measles Outbreak
por: Hu, Siyuan, et al.
Publicado: (2022)

Glomerulonephritis with monoclonal IgG deposits
por: Gandhi, K., et al.
Publicado: (2015)

Seroprevalence of SARS-CoV-2 IgM and IgG antibodies in an asymptomatic population in Sergipe, Brazil
por: Borges, Lysandro Pinto, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_obcs4nkmerv892m87kkh108s1b